Effects of atorvastatin and lisinopril on endothelial dysfunction in patients with Behçet's disease

Echocardiography

Volumn 27, Issue 8, 2010, Pages 997-1003

  Inanc, Mehmet Tugrul ^a   Kalay, Nihat ^a   Heyit, Turgun ^a   Ozdogru, Ibrahim ^a   Kaya, Mehmet Gungor ^a   Dogan, Ali ^a   Duran, Mustafa ^a   Kasapkara, Haci Ahmet ^a   Gunebakmaz, Ozgur ^a   Borlu, Murat ^a   Yarlioglues, Mikail ^a   Oguzhan, Abdurrahman ^a  

^a ERCIYES UNIVERSITY MEDICAL FACULTY   (Turkey)

Author keywords

atorvastatin; Beh et's disease; endothelial dysfunction; lisinopril

Indexed keywords

ATORVASTATIN; C REACTIVE PROTEIN; LISINOPRIL; PLACEBO;

ADULT; ARTERY BLOOD FLOW; ARTERY DILATATION; ARTICLE; BEHCET DISEASE; BRACHIAL ARTERY; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; DRUG EFFECT; ENDOTHELIAL DYSFUNCTION; FEMALE; GENERAL CONDITION IMPROVEMENT; HUMAN; INTRAVASCULAR ULTRASOUND; MAJOR CLINICAL STUDY; MALE; PRIORITY JOURNAL;

ADULT; ANTICHOLESTEREMIC AGENTS; ANTIHYPERTENSIVE AGENTS; BEHCET SYNDROME; DOUBLE-BLIND METHOD; ENDOTHELIUM, VASCULAR; FEMALE; HEPTANOIC ACIDS; HUMANS; LISINOPRIL; MALE; PLACEBO EFFECT; PYRROLES; TREATMENT OUTCOME; VENTRICULAR DYSFUNCTION, LEFT;

EID: 77956902025     PISSN: 07422822     EISSN: 15408175     Source Type: Journal    
DOI: 10.1111/j.1540-8175.2010.01180.x     Document Type: Article

References (44)

1. Ehrlich GE : Vasculitis in Behcet's disease. Int Rev Immunol 1997 14 : 81 88.
2. Kosar F, Sahin I, Gullu H, et al : Acute myocardial infarction with normal coronary arteries in a young man with the Behcet's disease. Int J Cardiol 2005 99 : 355 357.
3. Chajek-Shaul T, Pisanty S, Knobler H, et al : HLA-B51 may serve as an immunogenetic marker for patients with Behcet's syndrome. Am J Med 1987 83 : 666 672.
4. Eksioglu-Demiralp E, Direskeneli H, et al : Neutrophil activation in Behcet's disease. Clin Exp Rheumatol 2001 19 : S19 S24.
5. Lee S, Bang D, Cho YH : Polymerase chain reaction reveals herpes simplex virus DNA in saliva of patients with Behcet's disease. Arch Dermatol Res 1996 288 : 179 183.
6. Oflaz H, Mercanoglu F, Karaman O, et al : Impaired endothelium-dependent flow-mediated dilation in Behcet's disease: More prominent endothelial dysfunction in patients with vascular involvement. Int J Clin Pract 2005 59 : 777 781.
7. Gullu H, Caliskan M, Erdogan D, et al : Patients with Behcet's disease carry a higher risk for microvascular involvement in active disease period. Ann Med 2007 39 : 154 159.
8. Mege JL, Dilsen N, Sanguedolce V, et al : Overproduction of monocyte derived tumor necrosis factor alpha, interleukin (IL) 6, IL-8 and increased neutrophil superoxide generation in Behcet's disease. A comparative study with familial Mediterranean fever and healthy subjects. J Rheumatol 1993 20 : 1544 1549.
9. Niwa Y, Miyake S, Sakane T, et al : Auto-oxidative damage in Behcet's disease-endothelial cell damage following the elevated oxygen radicals generated by stimulated neutrophils. Clin Exp Immunol 1982 49 : 247 255.
10. Chambers JC, Haskard DO, Kooner JS : Vascular endothelial function and oxidative stress mechanisms in patients with Behcet's syndrome. J Am Coll Cardiol 2001 37 : 517 520.
11. Buldanlioglu S, Turkmen S, Ayabakan HB, et al : Nitric oxide, lipid peroxidation and antioxidant defence system in patients with active or inactive Behcet's disease. Br J Dermatol 2005 153 : 526 530.
12. Hizli N, Sahin G, Sahin F, et al : Plasma prostacyclin levels in Behcet's disease (letter). Lancet 1985 1 : 1454.
13. Dupuis J, Tardif JC, Cernacek P, et al : Cholesterol reduction rapidly improves endothelial function after acute coronary syndromes. The RECIFE (reduction of cholesterol in ischaemia and function of the endothelium) trial. Circulation 1999 99 : 3227 3233.
14. Sumi D, Hayashi T, Thakur NK, et al : A HMG-CoA reductase inhibitor possesses a potent anti-atherosclerotic effect other than serum lipid lowering effects - the relevance of endothelial nitric oxide synthase and superoxide anion scavenging action. Atherosclerosis 2001 155 : 347 357.
15. Thenappan T, Ali Raza J, Movahed A : Aortic atheromas: Current concepts and controversies-a review of the literature. Echocardiography 2008 25 : 198 207.
16. Linz W, Wiemer G, Gohlke P, et al : Contribution of kinins to the cardiovascular actions of angiotensin-converting enzyme inhibitors. Pharmacol Rev 1995 47 : 25 49.
17. Dobrucki LW, Kalinowski L, Dobrucki IT, et al : Statin-stimulated nitric oxide release from endothelium. Med Sci 2001 7 : 622 627.
18. Anderson TJ, Meredith IT, Yeung AC, et al : The effect of cholesterol lowering and antioxidant therapy on endothelium-dependent vasomotion. N Eng J Med 1995 332 : 488 493.
19. Osto E, Coppolino G, Volpe M, et al : Restoring the dysfunctional endothelium. Curr Pharm Des 2007 13 : 1053 1068.
20. Tiefenbacher CP, Friedrich S, Bleeke T, et al : ACE inhibitors and statins acutely improve endothelial dysfunction of human coronary arterioles. Am J Physiol Heart Circ Physiol 2004 286 : H1425 H1432.
21. (No authors listed) Criteria for diagnosis of Behcet's disease. International Study Group for Behcet's Disease. Lancet 1990 335 : 1078 1080.
22. Kayikciolu M, Aksu K, Hasdemir C, et al : Endothelial functions in Behcet's disease. Rheumatol Int 2006 26 : 304 308.
23. Chang HK, Kim SK, Lee SS, et al : Arterial stiffness in Behcet's disease: Increased regional pulse wave velocity values. Ann Rheum Dis 2006 65 : 415 416.
24. Joannides R, Haefeli WE, Linder L, et al : Nitric oxide is responsible for flow-dependent dilatation of human peripheral conduit arteries in vivo. Circulation 1995 91 : 1314 1319.
25. José MG, Berta R, Cristina R, et al : 3-Hydroxy-3-Methylglutaryl coenzyme a reductase inhibition prevents endothelial NO synthase downregulation by atherogenic levels of Native LDLs Arterioscler Thromb Vasc Biol 2001 21 : 804.
26. Laufs U, Liao JK : Post-transcriptional regulation of endothelial nitric oxide synthase mRNA activity stability by Rho GTPase. J Biol Chem 1997 273 : 24266 24271.
27. Hayashidani S, Tsutsui H, Shiomi T, et al : Fluvastatin, a 3-hydroxy-3-methylglutaryl coenzyme a reductase inhibitor, attenuates left ventricular remodeling and failure after experimental myocardial infarction. Circulation 2002 105 : 868 873. (Pubitemid 34174929)
28. Laufs U, La Fata V, Plutzky J, et al : Upregulation of endothelial nitric oxide synthase by HMG CoA reductase inhibitors. Circulation 1998 97 : 1129 1135.
29. Dechend R, Fiebeler A, Park JK, et al : Amelioration of angiotensin II-induced cardiac injury by a 3-hydroxy-3-methylglutaryl coenzyme a reductase inhibitor. Circulation 2001 104 : 576 581.
30. Vaughan CJ, Murphy MB, Buckley BM : Statins do more than just lower cholesterol. Lancet 1996 348 : 1079 1082.
31. Kalinowski L, Dobrucki LW, Brovkovych V, et al : Increased nitric oxide bioavailability in endothelial cells contributes to the pleiotropic effect of cerivastatin. Circulation 2002 105 : 933 938.
32. Lee AFC, Dick JBC, Struthers AD : Can lisinopril improve endothelial function in hyperlipidaemics J Am Coll Cardiol 1997 29 : 46A. Abstract.
33. Rakugi H, Kim DK, Krieger JE, et al : Induction of angiotensin converting enzyme in the neointima after vascular injury: Possible role in restenosis. J Clin Invest 1994 90 : 449 455.
34. Anderson TJ, Elstein E, Haber H, et al : Comparative study of ACE inhibition, angiotensin II antagonism, and calcium channel blockade on flow-mediated vasodilation in patients with coronary disease (BANFF study). J Am Coll Cardiol 2000 35 : 60 66.
35. Mombouli JV, Illiano S, Nagao T, et al : Potentiation of endothelium-dependent relaxations to bradykinin by angiotensin I converting enzyme inhibitors in canine coronary artery involves both endothelium-derived relaxing and hyperpolarizing factors. Circ Res 1992 71 : 137 144.
36. Dogra GK, Watts GF, Chan DC, et al : Statin therapy improves brachial artery vasodilator function in patients with Type 1 diabetes and microalbuminuria. Diabet Med 2005 22 : 239 242.
37. Ghiadoni L, Magagna A, Kardasz I, et al : Fixed dose combination of perindopril and indapamide improves peripheral vascular function in essential hypertensive patients. Am J Hypertens 2009 22 : 506 512.
38. Yildirim N, Tekin NS, Tekin IO, et al : Myocardial functional and textural findings of the right and left ventricles and their association with cellular adhesion molecules in Behcet's disease. Echocardiography 2007 24 : 702 711.
39. Nishimoto M, Takai S, Fukumoto H, et al : Increased local angiotensin II formation in aneurysmal aorta. Life Sci. 2002 71 : 2195 2205.
40. Charpiot P, Rolland PH, Friggi A, et al : ACE inhibition with perindopril and atherogenesis-induced structural and functional changes in minipig arteries. Arterioscler Thromb 1993 13 : 1125 1138.
41. Yurdakul S, Hamuryudan V, Yazici H : Behet syndrome. Curr Opin Rheumatol 2004 16 : 38 42.
42. Azizlerli G, Köse AA, Sarica R, et al : Prevalence of Behcet's disease in Istanbul, Turkey. Int J Dermatol 2003 42 : 803 806.
43. Bang D, Yoon KH, Chung HG, et al : Epidemiological and clinical features of Behcet's disease in Korea. Yonsei Med J 1997 38 : 428 436.
44. Caliskan M, Yilmaz S, Yildirim E, et al : Endothelial functions are more severely impaired during active disease period in patients with Behcet's disease. Clin Rheumatol 2007 26 : 1074 1078.